Financial results - ENDOMETABOLIC RESEARCH SRL

Financial Summary - Endometabolic Research Srl
Unique identification code: 36272634
Registration number: J2016009107404
Nace: 8621
Sales - Ron
17.187
Net Profit - Ron
3.978
Employees
1
Open Account
Company Endometabolic Research Srl with Fiscal Code 36272634 recorded a turnover of 2023 of 17.187, with a net profit of 3.978 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Endometabolic Research Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 6.619 23.533 32.887 43.695 23.638 19.205 37.951 17.283 -
Total Income - EUR - 6.619 23.533 32.977 43.938 23.640 19.205 38.119 17.283 -
Total Expenses - EUR - 1.247 2.946 7.561 11.088 14.511 3.193 14.214 13.110 -
Gross Profit/Loss - EUR - 5.372 20.587 25.416 32.849 9.129 16.011 23.904 4.173 -
Net Profit/Loss - EUR - 5.173 19.881 24.419 31.531 8.427 15.447 22.761 4.000 -
Employees - 0 0 0 0 0 0 0 1 -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -54.3%, from 37.951 euro in the year 2022, to 17.283 euro in 2023. The Net Profit decreased by -18.692 euro, from 22.761 euro in 2022, to 4.000 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Endometabolic Research Srl

Rating financiar

Financial Rating -
ENDOMETABOLIC RESEARCH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Endometabolic Research Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Endometabolic Research Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Endometabolic Research Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Endometabolic Research Srl - CUI 36272634

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 0 0 1.665 1.056 471 0 0 0 -
Current Assets - 5.448 25.372 48.513 78.612 77.923 88.882 101.487 122.972 -
Inventories - 0 0 0 0 0 0 0 8.615 -
Receivables - 0 1.620 10.178 27.296 16.885 29.300 31.297 26.614 -
Cash - 5.448 23.751 38.335 51.316 61.037 59.581 70.189 87.743 -
Shareholders Funds - 5.218 25.011 48.970 76.891 74.946 83.410 94.477 98.191 -
Social Capital - 45 44 43 42 41 40 41 40 -
Debts - 230 361 1.207 2.777 3.448 5.471 7.009 24.781 -
Income in Advance - 0 0 0 0 0 0 0 0 -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 122.972 euro in 2023 which includes Inventories of 8.615 euro, Receivables of 26.614 euro and cash availability of 87.743 euro.
The company's Equity was valued at 98.191 euro, while total Liabilities amounted to 24.781 euro. Equity increased by 4.000 euro, from 94.477 euro in 2022, to 98.191 in 2023.

Risk Reports Prices

Reviews - Endometabolic Research Srl

Comments - Endometabolic Research Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.